Opioid Alternatives Face an Uphill Battle Against Insurers and Doctors
Bloomberg Businessweek Opioid Alternatives Face an Uphill Battle Against Insurers
SRP-001: redefining pain treatment with a safer, non-opioid analgesic
Drug Target Review SRP-001: redefining pain treatment with a safer,
Safer Non-Opioid Pain Relief on the Horizon: SRP-001 Shows Promise in Phase 1 Trials
Health & Pharma Safer Non-Opioid Pain Relief on the Horizon:
Examining the mechanisms and clinical potential of a promising non-opioid pain therapy candidate
Medical Xpress Examining the mechanisms and clinical potential of a
Ochsner Health Highlights Innovative Non-Opioid Pain Therapy Candidate Publication
News Wise Ochsner Health Highlights Innovative Non-Opioid Pain Therapy Candidate
Novel Non-Addictive, Non-Toxic Painkiller Developed at LSU Health New Orleans
LSU Health New Orleans Novel Non-Addictive, Non-Toxic Painkiller Developed at
South Rampart Pharma’s quest to deliver innovative non-opioid pain solutions
Outsourcing Pharma South Rampart Pharma's quest to deliver innovative non-opioid
Ochsner Health physician granted NIH Trailblazer Award
Eureka Alert! Ochsner Health physician granted NIH Trailblazer Award February
Global Business Report
Global Business Reports Global Business Report October 17, 2023 Can
South Rampart Pharma Receives FDA Fast Track Designation
Biz New Orleans South Rampart Pharma Receives FDA Fast Track